The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Novel Roles of Unphosphorylated STAT3 in Oncogenesis and Transcriptional Regulation
Open accessAbstract
Signal transducer and activator of transcription 3 (STAT3) is phosphorylated on tyrosine residue 705 in response to growth factors or cytokines to form activated homodimers that drive gene expression. Because the stat3 promoter has a binding site for STAT3 dimers, the amount of STAT3 protein increases when STAT3 is activated (e.g., in response to interleukin 6). Unphosphorylated STAT1 is known to drive the expression of certain genes. To explore the possibility of a similar role for the induced expression of unphosphorylated STAT3, we overexpressed either Y705F STAT3, which can not be phosphorylated on residue 705, or wild-type STAT3 in normal human mammary epithelial cells or STAT3-null mouse cells. The levels of many mRNAs were affected strongly by high levels of either form of STAT3. Some genes whose expression was increased by overexpressed STAT3, but not by activated STAT3 dimers, encode well-known oncoproteins (e.g., MRAS and MET). In many tumors, STAT3 is activated constitutively, and thus the unphosphorylated form is likely to be expressed highly, driving oncogene expression by a novel mechanism. In addition, expression of the stat3 gene is increased strongly in response to interleukin 6, and the high levels of unphosphorylated STAT3 that result drive a substantial late phase of gene expression in response to this cytokine. Thus, unphosphorylated STAT3, which activates gene expression by a novel mechanism distinct from that used by STAT3 dimers, is very likely to be an important transcription factor both in cancer and in responses to cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, their efficacy is diminished because the inherent transcriptional activity of unphosphorylated STAT3 could also drive the expression of oncogenes such as MET and MRAS by binding to NF-κB (18–21).”
From Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer (2022) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Second, the targeted STAT3 degradation can completely inhibit the transcriptional activity of both dimerized and monomeric STAT3 (19, 21, 26).”
From Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer (2022) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“and that basal STAT3 has been shown to have transcriptional activity under basal conditions [44,45]”
From Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes (2012) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,840
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Three-dimensional structure of the Stat3β homodimer bound to DNA
Becker, S., Groner, B., & Müller, C. W. (1998) · Nature · doi:10.1038/28101 · Cited by 802
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA
Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J. E., Jr., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81443-9 · Cited by 734
Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani, K., DeGregori, J. V., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12146 · Cited by 640
The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.
Wagner, B. J., Hayes, T. E., Hoban, C. J., & Cochran, B. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07898.x · Cited by 592
Research works printed but not linked: 1
- Reddy MVR, Chaturvedi P, Reddy EP. Src kinase mediated activation of STAT3 plays an essential role in the proliferation and oncogenicity of human breast, prostate and ovarian carcinomas. Proc AACR 1999;40:376.
Cited by
Sorted by citations
Items 101–200 of 404
Leslie, K., Gao, S. P., Berishaj, M., Podsypanina, K., Ho, H. H., Ivashkiv, L. B., & Bromberg, J. (2010) · Breast Cancer Research · doi:10.1186/bcr2725 · Cited by 82
STAT3: A Potential Drug Target for Tumor and Inflammation
Hu, Y. S., Han, X., & Liu, X. H. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190620145052 · Cited by 81
The Roles of Post-Translational Modifications in STAT3 Biological Activities and Functions
Tesoriere, A., Dinarello, A., & Argenton, F. (2021) · Biomedicines · doi:10.3390/biomedicines9080956 · Cited by 80
IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain
Zhang, L., Badgwell, D. B., Bevers, J. J., Schlessinger, K., Murray, P. J., Levy, D. E., & Watowich, S. S. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9137-3 · Cited by 89
Self-citationRationally Designed Inhibitors Identify STAT3 N-Domain as a Promising Anticancer Drug Target
Timofeeva, O. A., Gaponenko, V., Lockett, S., Tarasov, S. G., Jiang, S., Michejda, C. J., Perantoni, A. O., & Tarasova, N. I. (2007) · ACS Chemical Biology · doi:10.1021/cb700186x · Cited by 79
Park, H. J., Li, J., Hannah, R., Biddie, S. C., Leal-Cervantes, A. I., Kirschner, K., Cruz, D. F. S., Sexl, V., Göttgens, B., & Green, A. R. (2015) · The EMBO Journal · doi:10.15252/embj.201592383 · Cited by 82
Courapied, S., Sellier, H., de Carné Trécesson, S., Vigneron, A., Bernard, A.-C., Gamelin, E., Barré, B., & Coqueret, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092304 · Cited by 76
STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation
Koganti, S. R. K., Hui‐Yuen, J. S., McAllister, S. C., Gardner, B., Grässer, F. A., Palendira, U., Tangye, S. G., Freeman, A. F., & Bhaduri‐McIntosh, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400683111 · Cited by 76
Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers
Brachet‐Botineau, M., Polomski, M., Neubauer, H. A., Juen, L., Hédou, D., Viaud‐Massuard, M., Prié, G., & Gouilleux, F. (2020) · Cancers · doi:10.3390/cancers12010240 · Cited by 77
Functional Regulatory Role of STAT3 in HPV16-Mediated Cervical Carcinogenesis
Shukla, S., Mahata, S., Shishodia, G., Pandey, A., Tyagi, A., Vishnoi, K., Basir, S., Das, B., & Bharti, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067849 · Cited by 78
Nkansah, E., Shah, R., Collie, G. W., Parkinson, G. N., Palmer, J. M., Rahman, K. M., Bui, T. T. T., Drake, A. F., Husby, J., Neidle, S., et al. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.065 · Cited by 79
HDAC Inhibition and Graft Versus Host Disease
Choi, S. W., & Reddy, P. R. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00007 · Cited by 75
Bao, L., Shi, V. Y., & Chan, L. S. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2011.12.008 · Cited by 74
STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Wei, L., Schuliga, M. J., Jaffar, J., Westall, G. P., Hansbro, P. M., Prêle, C. M., Mutsaers, S. E., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0328oc · Cited by 75
Lou, Y., Pan, X., Jia, P.-M., Li, D., Shu Dong, X. I. A. O., Zhang, Z., Chen, S., Zhu, C. H., & Tong, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4922 · Cited by 69
Human hyper-IgE syndrome: singular or plural?
Zhang, Q., Boisson, B., Béziat, V., Puel, A., & Casanova, J.-L. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9767-2 · Cited by 67
A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms
Hasselbalch, H. C. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.63 · Cited by 66
STAT-3 Activates NF-κB in Chronic Lymphocytic Leukemia Cells
Liu, Z., Hazan‐Halevy, I., Harris, D., Li, P., Ferrajoli, A., Faderl, S., Keating, M. J., & Estrov, Z. E. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0559 · Cited by 67
Hu, F., Geng, L., Huang, C., Hou, Z., Yang, X., Luo, X., Feng, Y., Wang, G., Hu, J., & Cao, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2467-3 · Cited by 71
Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells
Mehta, R. R., Katta, H., Alimirah, F., Patel, R., Murillo, G., Peng, X., Muzzio, M., & Mehta, R. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065113 · Cited by 67
DNA-triggered innate immune responses are propagated by gap junction communication
Patel, S. J., King, K. R., Casali, M., & Yarmush, M. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809292106 · Cited by 66
King, C. A. (2013) · Journal of Virology · doi:10.1128/jvi.02976-12 · Cited by 71
Pectasides, E., Egloff, A. M., Sasaki, C. T., Kountourakis, P., Burtness, B. A., Fountzilas, G., Dafni, U. G., Zaramboukas, T., Rampias, T. N., Rimm, D. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2658 · Cited by 65
Cyclin D1 Overexpression and Response to Bortezomib Treatment in a Breast Cancer Model
Ishii, Y., Pirkmaier, A., Alvarez, J. V., Frank, D. A., Keselman, I., Logothetis, D. E., Mandeli, J., O’Connell, M. J., Waxman, S., & Germain, D. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj334 · Cited by 65
Regulation of STATs by polycystin-1 and their role in polycystic kidney disease
Weimbs, T., Olsan, E. E., & Talbot, J. J. (2013) · JAK-STAT · doi:10.4161/jkst.23650 · Cited by 66
Non‐canonical Stat3 signaling in cancer
Srivastava, J., & DiGiovanni, J. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22438 · Cited by 64
Cui, X., Zhang, L., Luo, J., Rajasekaran, A., Hazra, S., Cacalano, N. A., & Dubinett, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210222 · Cited by 64
Noguchi, S., Yamada, N. O., Kumazaki, M., Yasui, Y., Iwasaki, J., Naito, S., & Akao, Y. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.11 · Cited by 64
Dasgupta, M., Unal, H., Willard, B., Yang, J., Karnik, S. S., & Stark, G. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603894 · Cited by 64
Self-citationMitochondrial STAT3: Powering up a potent factor
Garama, D. J., White, C. L., Balic, J. J., & Gough, D. J. (2016) · Cytokine · doi:10.1016/j.cyto.2016.05.019 · Cited by 64
Ng, I. H. W., Ng, D. C. H., Jans, D. A., & Bogoyevitch, M. A. (2012) · Biochemical Journal · doi:10.1042/bj20120941 · Cited by 63
Morgan, E. L., & Macdonald, A. (2020) · Viruses · doi:10.3390/v12090977 · Cited by 64
Wang, M., Meng, B., Liu, Y., Yu, J., Chen, Q., & Liu, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485907 · Cited by 62
Liu, D., Hu, G.-Y., Long, G., Qiu, H., Mei, Q., & Hu, G. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.18 · Cited by 62
Roles of inflammation in cancer initiation progression and metastasis
Wilber, A. C. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s55 · Cited by 62
Mirzaei, S., Gholami, M. H., Mahabady, M. K., Nabavi, N., Zabolian, A., Banihashemi, S. M., Haddadi, A., Entezari, M., Hushmandi, K., Makvandi, P., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111077 · Cited by 61
RetractedSTAT3 and p53: Dual Target for Cancer Therapy
Pham, T., Park, H., Kim, J., Hong, J. T., & Yoon, D. (2020) · Biomedicines · doi:10.3390/biomedicines8120637 · Cited by 63
Baus, D., & Pfitzner, E. (2005) · International Journal of Cancer · doi:10.1002/ijc.21539 · Cited by 61
A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells
Wojcik, E. J., Sharifpoor, S., Miller, N., Wright, T. G., Watering, R., Tremblay, E. A., Swan, K., Mueller, C. R., & Elliott, B. E. (2005) · Oncogene · doi:10.1038/sj.onc.1209306 · Cited by 63
Zaanan, A., Okamoto, K., Kawakami, H., Khazaie, K., Huang, S., & Sinicrope, F. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657833 · Cited by 59
MIR506induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway
Sun, L., Hu, L., Cogdell, D. E., Lü, L., Gao, C., Tian, W., Zhang, Z., Kang, Y., Fleming, J. B., & Zhang, W. (2017) · Autophagy · doi:10.1080/15548627.2017.1280217 · Cited by 58
Yang, M., Lee, H., Chen, C., Shen, C., & Ma, H. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150611013 · Cited by 60
Liu, Y., Tan, Y.-N., Wang, Z.-L., Zeng, L., Lu, Z., Li, L., Luo, W., Tang, M., & Cao, Y. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.2.153 · Cited by 60
Reitsma, J. M., Satō, H., Nevels, M. M., Terhune, S. S., & Paulus, C. (2013) · Journal of Virology · doi:10.1128/jvi.01197-13 · Cited by 62
Jin, J., Wu, Y., Zhao, Z., Wu, Y., Zhou, Y.-D., Liu, S., Sun, Q., Yang, G., Lin, J., Nagle, D. G., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160606 · Cited by 57
“Second, the targeted STAT3 degradation can completely inhibit the transcriptional activity of both dimerized and monomeric STAT3 (19, 21, 26).”
Signal transducers and activators of transcription—from cytokine signalling to cancer biology
Santos, C. I., & Costa‐Pereira, A. P. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.03.003 · Cited by 59
Yin, W., Cheepala, S., Roberts, J. N., Chan, K. S., DiGiovanni, J., & Clifford, J. L. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-15 · Cited by 56
Unlu, S., Kumar, A., Waterman, W. R., Tsukada, J., Wang, K. Z. Q., Galson, D. L., & Auron, P. E. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.016 · Cited by 57
Daigle, D., Megyola, C. M., El-Guindy, A. S., Gradoville, L., Tuck, D. P., Miller, G., & Bhaduri‐McIntosh, S. (2009) · Journal of Virology · doi:10.1128/jvi.01745-09 · Cited by 57
STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus
King, C. A., Li, X., Barbachano-Guerrero, A., & Bhaduri‐McIntosh, S. (2015) · Journal of Virology · doi:10.1128/jvi.02008-15 · Cited by 54
MRAS: A Close but Understudied Member of the RAS Family
Young, L. C., & Rodriguez-Viciana, P. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a033621 · Cited by 53
Hill, E. R., Koganti, S. R. K., Zhi, J., Megyola, C. M., Freeman, A. F., Palendira, U., Tangye, S. G., Farrell, P. J., & Bhaduri‐McIntosh, S. (2013) · Journal of Virology · doi:10.1128/jvi.01762-13 · Cited by 53
Andrianifahanana, M., Singh, A. P., Némos, C., Ponnusamy, M. P., Moniaux, N., Mehta, P. P., Varshney, G. C., & Batra, S. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210532 · Cited by 54
Constitutive nuclear import of latent and activated STAT5a by its coiled coil domain
Iyer, J. K., & Reich, N. C. (2007) · The FASEB Journal · doi:10.1096/fj.07-8965com · Cited by 57
The different functions of Stat5 and chromatin alteration through Stat5 proteins
Kornfeld, J. (2008) · Frontiers in bioscience · doi:10.2741/3151 · Cited by 52
Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
Tovar‐Palacio, C., Noriega, L. G., & Mercado, A. (2022) · Nutrients · doi:10.3390/nu14030653 · Cited by 52
How should we define STAT3 as an oncogene and as a potential target for therapy?
Sellier, H., Rébillard, A., Guette, C., Barré, B., & Coqueret, O. (2013) · JAK-STAT · doi:10.4161/jkst.24716 · Cited by 51
Kim, K. W., Mutter, R. W., Cao, C., Albert, J. M., Shinohara, E. T., Sekhar, K. R., & Lü, B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0261 · Cited by 52
Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway
Kamran, M. Z., & Gude, R. P. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.03.020 · Cited by 50
Seethala, R. R., Gooding, W. E., Handler, P. N., Collins, B. M., Zhang, Q. H., Siegfried, J. M., & Grandis, J. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1543 · Cited by 50
Differential Protein Distribution between the Nucleus and Mitochondria: Implications in Aging
Lionaki, E., Gkikas, I., & Tavernarakis, N. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00162 · Cited by 51
Stat3 regulates centrosome clustering in cancer cells via Stathmin/PLK1
Morris, E. J. S., Kawamura, E., Gillespie, J. A., Balgi, A. D., Kannan, N., Muller, W. J., Roberge, M., & Dedhar, S. (2017) · Nature Communications · doi:10.1038/ncomms15289 · Cited by 49
Xu, F., Mukhopadhyay, S., & Sehgal, P. B. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00220.2007 · Cited by 49
Arany, I., Reed, D. K., Grifoni, S. C., Chandrashekar, K., Booz, G. W., & Juncos, L. A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00338.2011 · Cited by 49
Dunkel, Y., Ong, A., Notani, D., Mittal, Y., Lam, M. T. Y., Mi, X., & Ghosh, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390781 · Cited by 46
Nishimoto, A., Kugimiya, N., Hosoyama, T., Enoki, T., Li, T., & Hamano, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.105 · Cited by 47
STAT3 as a new autophagy regulator
Jonchère, B., Bélanger, A., Guette, C., Barré, B., & Coqueret, O. (2013) · JAK-STAT · doi:10.4161/jkst.24353 · Cited by 48
βIV-Spectrin regulates STAT3 targeting to tune cardiac response to pressure overload
Unudurthi, S. D., Nassal, D. M., Greer-Short, A., Patel, N., Howard, T. S., Xu, X., Önal, B., Satroplus, T., Hong, D., Lane, C., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99245 · Cited by 47
Darnowski, J. W., Goulette, F. A., Guan, Y. A., Chatterjee, D., Yang, Z., Cousens, L. P., & Chin, Y. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600088200 · Cited by 47
Shen, X., Han, Y., Zhang, D., Cui, X., & Kim, N. (2009) · Molecular Reproduction and Development · doi:10.1002/mrd.21048 · Cited by 45
Signal integration and gene induction by a functionally distinct STAT3 phosphoform
Waitkus, M. S., Chandrasekharan, U. M., Willard, B., Tee, T. L., Hsieh, J. K., Przybycin, C. G., Rini, B. I., & DiCorleto, P. E. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00034-14 · Cited by 45
STAT3beta, a distinct isoform from STAT3
Zhang, H., Yang, P.-L., Li, E., & Xu, L. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.02.006 · Cited by 45
Galvani, G., Mottolese, N., Gennaccaro, L., Loi, M., Medici, G., Tassinari, M., Fuchs, C., Ciani, E., & Trazzi, S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02204-0 · Cited by 44
STAT3 Role in T-Cell Memory Formation
Kaminskiy, Y., & Melenhorst, J. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052878 · Cited by 44
Oncogenic Signaling Induced by HCV Infection
Virzì, A., Suarez, A. A. R., Baumert, T. F., & Lupberger, J. (2018) · Viruses · doi:10.3390/v10100538 · Cited by 47
Lee, H., Deng, J., Xin, H., Liu, Y., Pardoll, D., & Yu, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3304 · Cited by 44
Lamhamedi-Cherradi, S.-E., Menegaz, B. A., Ramamoorthy, V., Aiyer, R. A., Maywald, R. L., Buford, A. S., Doolittle, D. K., Culotta, K. S., O'Dorisio, J. E., & Ludwig, J. A. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0334 · Cited by 45
The nuclear events guiding successful nerve regeneration
Kiryu‐Seo, S., & Kiyama, H. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00053 · Cited by 43
Regulation of T cell homeostasis by JAKs and STATs
Ross, J. A., Nagy, Z. S., Cheng, H., Stepkowski, S. M., & Kirken, R. A. (2007) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-007-0030-x · Cited by 45
Inhibition of STAT3 reverses drug resistance acquired in temozolomide-resistant human glioma cells
LEE, E.-S., Ko, K.-K., Joe, Y. A., Kang, S., & Hong, Y.-K. (2010) · Oncology Letters · doi:10.3892/ol.2010.210 · Cited by 45
Longshaw, V. M., Baxter, M. A., Prewitz, M. C., & Blatch, G. L. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.09.003 · Cited by 42
Su, Y., Zhang, W., Patro, C. P. K., Zhao, J., Mu, T., Ma, Z., Xu, J., Ban, K. H.-K., Yi, C., & Zhou, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00362 · Cited by 41
The Dynamic Interface of Viruses with STATs
Harrison, A. R., & Moseley, G. W. (2020) · Journal of Virology · doi:10.1128/jvi.00856-20 · Cited by 43
Kalakonda, S., Nallar, S. C., Lindner, D. J., Hu, J., Reddy, S. P., & Kalvakolanu, D. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0031 · Cited by 42
Stat3 inhibits WTX expression through up‐regulation of microRNA‐370 in Wilms tumor
Cao, X., Liu, D., Yan, X., Zhang, Y., Yuan, L., Zhang, T., Fu, M., Zhou, Y., & Wang, J. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.012 · Cited by 41
STAT3 Cyclic Decoy Demonstrates Robust Antitumor Effects in Non–Small Cell Lung Cancer
Njatcha, C., Farooqui, M., Kornberg, A. E., Johnson, D. E., Grandis, J. R., & Siegfried, J. M. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1194 · Cited by 41
Betz, A., Ryoo, H. D., Steller, H., & Darnell, J. E., Jr. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806291105 · Cited by 40
Yao, K., Chen, Q., Wu, Y., Liu, F., Chen, X., & Zhang, Y. (2017) · Journal of Cell Science · doi:10.1242/jcs.200659 · Cited by 40
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
Rosell, R., Codony‐Servat, J., González, J., Santarpía, M., Jain, A. S., Shivamallu, C., Wang, Y., Giménez-Capitán, A. A., Molina‐Vila, M. Á., Nilsson, J. A., et al. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104228 · Cited by 42
Wang, H., Su, X., Yang, M., Chen, T., Hou, J., Li, N., & Cao, X. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1031440 · Cited by 39
Stat3: Linking inflammation to (gastrointestinal) tumourigenesis
Ernst, M., & Putoczki, T. L. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05659.x · Cited by 39
The Role of STAT3 in Thyroid Cancer
Sosonkina, N., Starenki, D., & Park, J. (2014) · Cancers · doi:10.3390/cancers6010526 · Cited by 41
Hösel, M., Quasdorff, M., Ringelhan, M., Kashkar, H., Debey-Pascher, S., Sprinzl, M., Bockmann, J., Arzberger, S., Webb, D., von Olshausen, G., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.07.003 · Cited by 38
Zhang, Y., Guo, S., Fang, J., Peng, B., Zhang, Y., & Cao, T. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6562 · Cited by 39
Sun, J., Du, Y., Song, Q., Jing, N., Guan, P., Guo, J., Wang, X., Yang, J., & Zhao, C. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy174 · Cited by 40
Self-citationVaclavicek, A., Bermejo, J. L., Schmutzler, R. K., Sutter, C., Wappenschmidt, B., Meindl, A., Kiechle, M. B., Arnold, N., Weber, B. H. F., Niederacher, D., et al. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0077 · Cited by 39
Koptyra, M., Gupta, S., Talati, P. G., & Nevalainen, M. T. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.06.007 · Cited by 37
Huang, Y., Huang, X., Yang, Y., Wang, W., Yu, Y., & Qin, Q. (2014) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2014.12.031 · Cited by 37
Consequences of the disease-related L78R mutation for dimerization and activity of STAT3
Domoszlai, T., Martincuks, A., Fahrenkamp, D., de Leur, H. S.-V., Küster, A., & Müller‐Newen, G. (2014) · Journal of Cell Science · doi:10.1242/jcs.137422 · Cited by 39
Dynamic trafficking of STAT5 depends on an unconventional nuclear localization signal
Shin, H., & Reich, N. (2013) · Journal of Cell Science · doi:10.1242/jcs.123042 · Cited by 44
Metadata
- Authors
- Yang, J., Chatterjee-Kishore, M., Staugaitis, S. M., Nguyen, H., Schlessinger, K., Levy, D. E., & Stark, G. R.
- Affiliations
- 1Molecular Biology and Departments of
- Cleveland Clinic (US)
- New York University (US)
- Venue
- Cancer Research
- Published
- 2005-02-01
- Volume
- 65
- Issue
- 3
- Pages
- 939-947
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2147314043
- Cited by
- 405
- References
- 38
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 14 · 2021: 14 · 2020: 16 · 2019: 13 · 2018: 20 · 2017: 18 · 2016: 20 · 2015: 19 · 2014: 22 · 2013: 29 · 2012: 24
- FWCI
- 12.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cleveland Clinic
- Johns Hopkins University
- National Institutes of Health
- School of Medicine, Indiana University
- National Cancer Institute (P01CA062220)
- National Institute of Allergy and Infectious Diseases (R01AI028900)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT3, tyrosine 705 phosphorylation, carcinogenesis, transcriptional regulation, interleukin-6, cytokine response, oncoprotein, mineralocorticoid receptor antagonists, MET, constitutive STAT3 activation, gene expression, mammary epithelial cells
- MeSH terms
- Animals, DNA-Binding Proteins, Female, Gene Expression Regulation, Humans, Neoplasms, Oncogenes, Phosphorylation, Proto-Oncogene Proteins, RNA, Messenger, Trans-Activators, Interleukin-6, Gene Expression Regulation, Neoplastic, Receptors, Growth Factor, ras Proteins, Proto-Oncogene Proteins c-met, Monomeric GTP-Binding Proteins, Mammary Glands, Human, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review